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HLA-D region related antigens have been shown to be expressed on B cells, a 
minor  population  of T  cells,  activated  T  cells,  monocytes, and  hematopoietic 
precursor  cells  (reviewed  in  1).  The  recently  described  HLA-linked  DC/DS 
antigens  (2,  3)  have  more  limited  cell  distribution  (4-6)  and  are  expressed 
predominantly on B cells, activated T  cells, and a minor population ofmonocytes. 
Although their expression is documented in cases of B cell chronic lymphocytic 
leukemia  (CLL),  they  are  infrequently found  on  cells  of acute  lymphoblastic 
leukemia  (ALL) of non-T  cell  type (4). l  Cell  lines  of ALL  origin  also  fail  to 
express these  antigens  (6).  In  addition,  nonlymphoid leukemia  cells as  well as 
precursor cells of the erythroid and myeloid series have been shown to lack them 
(5, 6). 
Phorboi esters have been found to exert a  variety of effects on hematopoietic 
cells  as  well  as  on  other  tissue  (7).  In  particular,  the  phorbol  ester,  12-0- 
tetradecanoylphorbol-13-acetate (TPA) has been shown to induce CLL cells to 
differentiate (8) and to cause phenotypic changes in ALL cells as well as causing 
ALL cell lines to express certain  B cell antigens (9,  10).  In the present investi- 
gation, TPA is shown to induce three precursor B cell lines to express HLA-DC/ 
DS antigens that are detected by the Leu 10 antibody. This is accompanied by a 
concomitant decrease in the expression of the common ALL antigen (CALLA) 
and the enzymatic activity of terminal deoxyribonucleotidyi tz-ansferase (TdT). 
Materials and Methods 
Cells and Culture Conditions.  Human non-T ALL cell lines Reh and Nalm 12 (11) were 
kindly provided by Dr.  P.  Ralph of the Memorial Sloan-Kettering Cancer Center. Cell 
line Josh-7 was derived from a  patient with X-linked agammaglobulinemia (12).  It has 
little detectable Ig and is HLA-DR  ÷, CALLA  +, and TdT-. Cell lines were maintained in 
RPMI-1640 with  10% heat-inactivated fetal calf serum, glutamine,  100 U/ml penicillin, 
and 100 #g/ml streptomycin (regular medium). 
TPA Cultures.  TPA (Sigma Chemical Co., St.  Louis, MO) was stored at -20°C at  1 
mg/ml in acetone. For induction experiments, cells were cultured in regular medium at 
5  ×  105  cells/ml.  TPA  was  added  to  yield appropriate  final  concentrations. Control 
cultures received an equal amount of acetone without TPA. 10 ml of cells were cultured 
in 25-cm  ~ flasks (Falcon Labware, Oxnard, CA) at 37°C in a humidified atmosphere of 
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5% CO.~. Media were changed every 2 d. Cells were maintained for 6-8 d with viability 
>80% by trypan blue exclusion. 
MonoclonalAntibodies.  An IgGl(CW) mouse monoclonal antibody against HLA-DR was 
prepared in our laboratory. Monoclonal anti-HLA-DR(BD) and Leu 10 antibodies were 
obtained from Becton, Dickinson & Co., Mountain View, CA. Anti-CALLA antibody J5 
was from Coulter Electronics, Inc., Hialeah, FL. Antibody ILR-1 directed against a HLA- 
SB antigen (13)  was kindly provided by Dr.  E. Yunis,  Sydney Farber Cancer Center, 
Boston, MA. All these antibodies were used at saturated concentrations. Normal mouse 
IgG (Cappei  Laboratories, Cochranville, PA) was used as a control at 100 ~g/ml. 
hnmunofluorescence.  Monoclonal antibody binding to cell surface was detected by flow 
cytometry with a FACS IV (B-D FACS systems, Becton, Dickinson & Co., Sunnyvale, CA). 
5  ×  105  cells were incubated with  100  ~1  of supernatants at 4°C  for  1 h.  After two 
washings with phosphate-buffered saline, the cells were stained with 100 #1 of fluorescein- 
conjugated F(ab')2  fragments of affinity-purified goat anti-mouse Ig antibodies (Cappel 
Laboratories) for 1 h. After three washes, the cells were analyzed. 
TdT assa~,.  Enzymatic detection of TdT was carried out as described previously (14). 
lodination,  hnmunoprecipitation, and  Two-dimensional Gel  Electrophoresis.  Cell  surface 
iodination and immunoprecipitation were performed as described previously (15).  Im- 
munoprecipitated material was analyzed on a two-dimensional gel system, modified from 
the technique of O'Farrell et al. (16). First-dimensional resolution was performed on an 
isoelectric  focusing (IEF) slab gel with pH 3.5-10 ampholines. The slabs were then sliced 
into strips for subsequent second-dimensional resolution with sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (SDS-PAGE).  Marker proteins of known molecular 
weight were co-electrophoresed on each SDS-PAGE gel. Gels were then stained, dried on 
filter paper under vacuum, and autoradiographed on Kodak X-Omat R film. 
Results 
TPA Induction  of  HLA-DC/DS Antigen and Disappearance of CALLA by Immunoflu- 
orescence.  Three  cell  lines (Josh  7,  Reh,  and  Nalm  12)  were  selected for  this 
investigation.  By immunofluorescence, Josh  7  and  Reh  did  not  make any  Ig 
whereas  Nalm  12  made  only cytoplasmic t~  chains.  These  cell  lines  represent 
human precursor and pre-B cell lines (11,  12).  Immunofluorescence studies as 
shown  in  Fig.  1A  indicated  that  they  expressed  HLA-DR  antigens  (>85% 
positive) as detected by two monocional anti-HLA-DR (BD and CW) reagents. 
Although not shown, antibody ILR-1,  reactive  with SB  antigens (13),  stained 
these cell lines in a similar manner. All three cell lines expressed CALLA (>80% 
positive) as detected by antibody J5.  In contrast, very few cells stained with the 
antibody Leu 10, which reacts with HLA-DC/DS molecules linked to HLA-DR 
1-6  but not with those linked to HLA-DR7  (F.  Brodsky, Becton, Dickinson & 
Co., Mountain View, CA, personal communication and 17). 
The expression of HLA-DR,HLA-DC/DS, and CALLA antigens were studied 
further  with  the  addition  of TPA  to  the  cultures.  Preliminary  experiments 
indicated that 1.6 ×  10 -9 M was optimal for induction studies. This concentration 
was  used  for  all  subsequent  experiments.  TPA  at  this  concentration  induced 
marked morphological changes in all three cell lines. Analysis with [3H]thymidine 
incorporation  indicated  that  DNA  synthesis  was  markedly  inhibited  in  these 
cultures. Care has also been taken to change media every other day to maintain 
>80% viability in all cultures studied. 
TPA  was  found to induce  HLA-DC/DS antigen expression  in all three  cell 
lines (Fig.  1 B). An increase in Leu  10 + cells in TPA-treated Josh 7 cultures was 
evident after 96 h of incubation. After 6 d, >80% of cells in TPA-treated cultures 
stained  positive  for  the  antibody  Leu  10.  In  addition,  there  were  changes  in WANG  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIGURE  1.  Indirect  immunofluorescence  analysis by  flow  cytometry.  (A)  Day  6,  control 
cultures; (B) day 6, TPA-treated cultures; (--  -) control using mouse Ig; (jagged line) HLA- 
DC/DS detected by monolconal antibody Leu  10; (...)  CALLA detected by monoclonal 
antibody  J5; and (~)  HLA-DR  detected by monoclonal antibody anti-HLA-DR (CW). 
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FIGURZ 2.  Two-dimensional gel electrophoresis of iodinated molecules precipitated by (a) 
monoclonal antibody anti-HLA-DR (CW), (b) monoclonal antibody anti-HLA-DR (BD), and 
(c) monoclonal antibody Leu  10.  la, Ib, and lc were from control Josh 7 cells and 2a, 2b, and 
2c were from TPA-treated Josh 7 cells. 
CALLA expression.  In the case of  Josh 7, >80% of control cells were CALLA  + 
and only 15% of the TPA-treated cells were stained. Similar results were obtained 
in Reh and  Nalm  12.  TdT enzymatic activity was also determined  in Reh and 
Nalm  12. After TPA treatment,  TdT was not detectable in Nalm  12 (from 0.43 
nmol/108 cells to 0) and a >90% reduction (from  1.40 nmol/108 to 0.11  nmol/ 
108) of enzyme activity was observed in Reh.  In contrast,  there were no appre- 
ciable changes in HLA-DR and HLA-SB antigen expression in the TPA-treated 
cultures of all cell lines. There were also no changes in the Ig expression patterns 
and no induction of expression of sheep erythrocyte receptors. 
Further Evidence  for HLA-DC/DS Induction.  Two additional experiments were 
carried out to document TPA induction of HLA-DC/DS expression in precursor 
B cell lines.  30 x  106 cells from day 6 Josh 7 control and TPA-treated cultures 
were iodinated by the lactoperoxidase method. After solubilization, immunopre- 
cipitates with two monoclonal antibodies against HLA-DR antigens (BD and CW) 
and monoclonai antibody Leu 10 were obtained and analyzed by two-dimensional 
gel electrophoresis  (IEF,  SDS-PAGE).  As shown  in  Fig.  2,  both anti-HLA-DR 
antibodies precipitated  a  29,34  kD bimolecular complex from the control and 
TPA-treated cultures (Fig.  2  la,  lb, 2a, and 2b). In contrast,  antibody Leu  10 
did not precipitate any discernable components from the control culture (Fig. 2 1760  WANG  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIGURE 3.  Absorption of monoclonal antibody Leu 10 with cell lysates.  Monoclonal antibody 
Leu 10 was absorbed with varying amount of cells from different cell lines and the supernatants 
were used to stain TPA-treated Josh 7 cells.  Control cells from Josh 7 (,), Reh (Q), and molt 
4 (A). TPA-treated cells from Josh 7 (r-I) and Reh (O). 
lc) as well as from untreated cultures (not shown). However, a distinct molecular 
complex with a  similar  molecular weight to that  of the  HLA-DR antigen  and 
with a much wider isoelectric point range for both the a  and/3 chains (as shown 
in Fig. 2 2c) was observed in TPA-treated Josh 7 cells. 
Absorption experiments were carried out to determine the amount of HLA- 
DC/DS antigen  expressed by TPA-treated cells. For control experiments, Josh 
7 and Reh, as well as Molt 4, a T  cell line that did not express Leu  10 antigen 
and which was not inducible, were used. TPA-treated Josh 7 and Reh cells were 
pelleted and  disrupted  by three freeze and thaw cycles. Antibody Leu  10 was 
used at  a  concentration  two-fold above the  end  point.  After absorptions,  the 
antibody was used to stain day 6  TPA-treated Josh 7 cells. As shown in Fig.  3, 
TPA-treated  Josh  7  and  Reh  cells  were  efficient  in  removing  the  Leu  10 
reactivity.  Untreated  Reh cells were able to remove some Leu  10 antibody at 
high cell concentrations. Both Molt 4 and untreated Josh 7 cells failed to remove 
any  Leu  10 activity.  Quantitatively,  TPA-treated Josh  7  cells as well as TPA- 
treated Reh cells were at least 25-fold more efficient in removing Leu 10 antibody 
activity than their respective untreated cells, indicating a significant induction of 
Leu 10 antigen synthesis and expression after TPA treatment. 
Discussion 
Three  methods,  i.e.,  immunofluorescence,  biochemical  identification,  and 
absorption, have been used to show that TPA can induce precursor and pre-B 
cell lines to express the HLA-DC/DS antigens.  This expression is accompanied 
by the disappearance of CALLA and a marked reduction of TdT. These changes 
indicate  more  mature  phenotypic  expression.  LeBien and  coworkers (9) have 
shown that TPA induced Reh to express BA-2 antigen (p24) with a concomitant 
decrease in TdT expression. In four common ALL cell lines, Nadler et al. (10) 
reported  that  TPA  induced  the  expression  of B1  antigen.  In  their  study,  the 
expression of CALLA was not significantly changed. This difference may be due WANG  ET  AL.  BRIEF  DEFINITIVE  REPORT  1761 
to the shorter time course in their study. Nevertheless, their results suggest that 
most non-T ALL cell lines can be induced to mature in vitro. 
The monoclonal antibody Leu 10 precipitated a 29,34 kD bimolecular complex 
with different a  and/~ chains from those of HLA-DR antigens. The antibody 
stains B cells from donors with HLA-DR  1-6 and B cell lines transformed by 
Epstein-Barr virus.  In addition, few bone marrow cells (a much lower number 
than that of HLA-DR-positive cells) have been found to express this antigen. 
The studies carried out by F. Brodsky (personal communication) at the Becton 
Dickinson Monoclonal Center, Inc. have led to the conclusion that the Leu  10 
antigenic determinant  is  expressed  on  the  HLA-DC/DS  molecules linked  to 
HLA-DR  1-6.  This antibody has broader reactivity than the antibody Genox 
3.53, which detects a polymorphic determinant on DC/DS molecules linked to 
DR1,  DR2,  and  DR6  (17).  The  complexity of the  HLA-D  region  antigenic 
specificities is beyond the scope of this report. It suffices to state that both Leu 
10  and  Genox  3.53  antibodies  give  similar  cell  staining patterns  in  reactive 
individuals.  It is of interest to note that  the DC/DS  determinant detected by 
Genox 3.53 is not expressed on AML blasts and precursor cells of the erythroid 
and  myeloid series (4,  5).  In  addition,  Genox  3.53  fails to  stain  TdT  + bone 
marrow cells and only 20% of the pre-B cells are positive (6). It appears that DC/ 
DS expression is limited to more mature stages of B cell differentiation. In the 
present study, the failure of control Josh 7 cell lysate to absorb Leu 10 antibody 
and the efficient removal of this antibody by TPA-treated Josh 7 lysate indicate 
that newly synthesized DC/DS molecules are induced. Thus, it appears that there 
is a stage of human B cell differentiation with phenotypes TdT-, CALLA-, Ig-, 
DR  +, and DC/DS +. The expression of HLA-DC/DS antigen precedes the expres- 
sion of membrane Ig but  follows the expression of HLA-DR antigen. This is 
perhaps relevant to the role of these molecules in cell interaction in subsequent 
B cell development. 
Summary 
The expression of HLA-DC/DS antigen detected by the monoclonal antibody 
Leu 10 was studied in three human precursor and pre-B cell lines (Josh 7, Reh, 
and  Nalm  12).  Flow cytometric analysis showed that  none of these cell  lines 
stained for the HLA-DC/DS antigen. In the presence of 1.6 x  10 -° M of 12-0- 
tetradecanoylporbol-13-acetate (TPA), expression of this antigen was detected. 
The  expression  was  completed after  168  h  of incubation.  Iodination  of cell 
surface,  immunoprecipitation  by  Leu  10  antibody,  and  two-dimensional  gel 
analysis revealed that TPA-treatedJosh 7 cells synthesized and expressed a 29,34 
kD bimolecular complex with both a  and/3 chains different from those of HLA- 
DR antigen.  Quantitative absorption  experiments with cell lysates indicated a 
>25-fold increase in HLA-DC/DS antigen in TPA-treated cells. 
With the induction of HLA-DC/DS antigen expression, there are concomitant 
decreases in the expression of the common acute lymphoblastic leukemia antigen 
(CALLA) and the enzymatic activity of terminal deoxynucleotidyl transferase. 
No appreciable changes in  HLA-DR and Ig expression were observed. There 
was  also  no  change  in  HLA-SB  expression  as  detected by  antibody  ILR-1. 
However,  DNA  synthesis  was  markedly inhibited  by  TPA  treatment.  These 
results indicate that precursor and pre-B cell lines can be induced to mature in 1762  WANG  ET  AL.  BRIEF  DEFINITIVE REPORT 
vitro.  They  also  suggest  that  the  expression  of  HLA-DC/DS  antigen  which 
precedes the expression of membrane Ig and follows the HLA-DR expression is 
relevant to human B cell development and cell interaction. 
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